Drug Profile
Research programme: EP4 receptor modulators - Ariel Pharmaceuticals
Alternative Names: EP4 receptor agonists - Ariel Pharmaceuticals; EP4 receptor antagonists - Ariel Pharmaceuticals; Prostanoid EP4 receptor ligands - Ariel PharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ariel Pharmaceuticals
- Class
- Mechanism of Action Prostaglandin E EP4 receptor antagonists; Prostaglandin E EP4 receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Migraine
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in USA
- 16 Jul 2016 No recent reports of development identified for research development in Migraine in USA
- 23 Sep 2011 Early research in Inflammation in USA (unspecified route)